Old Web
English
Sign In
Acemap
>
Paper
>
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
2017
Neil H. Segal
Theodore F. Logan
F. Stephen Hodi
David F. McDermott
Ignacio Melero
Omid Hamid
Henrik Schmidt
Caroline Robert
Vanna Chiarion Sileni
Paolo Antonio Ascierto
Michele Maio
Walter J. Urba
Tara C. Gandadhar
Satyendra Suryawanshi
Jaclyn Neely
Maria Jure-Kunkel
Suba Krishnan
Holbrook Kohrt
Mario Sznol
Ronald Levy
Keywords:
Virology
CD137
Monoclonal antibody
Hepatitis
Agonist
Medicine
Pharmacology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]